相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer
Julia Rose Salinaro et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm A Randomized Clinical Trial
Saketh R. Guntupalli et al.
JAMA NETWORK OPEN (2020)
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
James D. Douketis et al.
JAMA INTERNAL MEDICINE (2019)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary
Nigel S. Key et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry
Walter Ageno et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
Silvia Riondino et al.
CANCERS (2019)
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
Andres J. Munoz Martin et al.
BRITISH JOURNAL OF CANCER (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
Wonkyung Byon et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
M. Di Nisio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 Featured Updates to the NCCN Guidelines
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Characterization of Risk Factors and Timing of Venous Thromboembolism in Patients With Uterine Serous Carcinoma
Gregory M. Gressel et al.
OBSTETRICS AND GYNECOLOGY (2018)
Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
M. Jose Martinez-Zapata et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Prevention of venous thromboembolism in gynecologic oncology surgery
Emma L. Barber et al.
GYNECOLOGIC ONCOLOGY (2017)
Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study
Natale Daniele Brunetti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Venous Thromboembolism in Gynecological Malignancy
Abigail Cohen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment
S. Noble et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
Hakeam A. Hakeam et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
Chiara Alessandra Cella et al.
ONCOLOGIST (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
James D. Douketis et al.
THROMBOSIS AND HAEMOSTASIS (2017)
The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer
N. van Es et al.
THROMBOSIS RESEARCH (2017)
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting A Scientific Statement From the American Heart Association
Amish N. Raval et al.
CIRCULATION (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer
A. S. Mansfield et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Perioperative Management of Dabigatran A Prospective Cohort Study
Sam Schulman et al.
CIRCULATION (2015)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
James D. Douketis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants
Florian Posch et al.
THROMBOSIS RESEARCH (2015)
Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
Marc Carrier et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Anticoagulant Therapy for the Treatment of Acute Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis
Marc Carrier et al.
THROMBOSIS RESEARCH (2014)
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
Alok A. Khorana et al.
CANCER (2013)
Perioperative care in gynecologic oncology
Christina L. Kushnir et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2013)
Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis
Gary H. Lyman et al.
ONCOLOGIST (2013)
Perioperative Management of Antithrombotic Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
James D. Douketis et al.
CHEST (2012)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Michael Rud Lassen et al.
LANCET (2010)
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer -: A systematic review and meta-analysis
Elie A. Akl et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Risk factors for venous thromboembolic events in cancer patients
K Kröger et al.
ANNALS OF ONCOLOGY (2006)
Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy
RL DeBernardo et al.
OBSTETRICS AND GYNECOLOGY (2005)
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz et al.
CIRCULATION (2004)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
P Mismetti et al.
BRITISH JOURNAL OF SURGERY (2001)
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
JD Douketis et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
